The high mutation rate of PBRM1 in ccRCC has been confirmed by multiple studies (Cancer Genome Atlas Research Network, 2013; Dalgliesh et al., 2010; Guo et al., 2012; Pena‐Llopis et al., 2012; Sato et al., 2013). Here, PBRM1 is linked to nonpapillary renal cell carcinoma.